Research Paper Volume 13, Issue 8 pp 11988—12006

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia

Association between COMMD7 expression and clinical features and cytogenetic risks. (A) The diagnostic efficacy of COMMD7 in acute myelogenous leukemia analyzed by ROC. (B–H) Association between COMMD7 expression and BM blasts (20%), WBC counts (20 × 109), FAB classification, cytogenetics risk, NPM1 mutation, FLT3 mutation, and IDH1 R132 mutation analyzed by using Wilcoxon Rank SUM test.

Figure 7. Association between COMMD7 expression and clinical features and cytogenetic risks. (A) The diagnostic efficacy of COMMD7 in acute myelogenous leukemia analyzed by ROC. (BH) Association between COMMD7 expression and BM blasts (20%), WBC counts (20 × 109), FAB classification, cytogenetics risk, NPM1 mutation, FLT3 mutation, and IDH1 R132 mutation analyzed by using Wilcoxon Rank SUM test.